Trial Profile
Oral montelukast versus inhaled steroids for mild persistent asthma among 1 to 5 year old children
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Oct 2020
Price :
$35
*
At a glance
- Drugs Montelukast (Primary) ; Beclometasone
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Getz Pharma
- 05 Oct 2020 Status changed from recruiting to completed.
- 04 Nov 2011 New trial record